AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

$129.80
-7.20 (-5.26%)
As of Nov 5, 9:49 PM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 26 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -49.1% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $129.80
Current
$129.80
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-63.3%
Low target
Base Case
$66.03
-49.1%
Avg target
Bull Case
$88.20
+-32.0%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$260.19
-50.1% from high
52-Week Low
$123.50
+5.1% from low
50-Day SMA
$180.64
-28.1% vs SMA
200-Day SMA
$198.71
-34.7% vs SMA
RSI (14)
21.9
Oversold
Target vs 52W High
$66.03
-74.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%